A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes

Michelle J. Pena, Andreas Heinzel, Georg Heinze, Alaa Alkhalaf, Stephan J. L. Bakker, Tri Q. Nguyen, Roel Goldschmeding, Henk J. G. Bilo, Paul Perco, Bernd Mayer, Dick de Zeeuw, Hiddo J. Lambers Heerspink*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective

We aimed to identify a novel panel of biomarkers predicting renal function decline in type 2 diabetes, using biomarkers representing different disease pathways speculated to contribute to the progression of diabetic nephropathy.

Research Design and Methods

A systematic data integration approach was used to select biomarkers representing different disease pathways. Twenty-eight biomarkers were measured in 82 patients seen at an outpatient diabetes center in The Netherlands. Median follow-up was 4.0 years. We compared the cross-validated explained variation (R-2) of two models to predict eGFR decline, one including only established risk markers, the other adding a novel panel of biomarkers. Least absolute shrinkage and selection operator (LASSO) was used for model estimation. The C-index was calculated to assess improvement in prediction of accelerated eGFR decline defined as

Results

Patients' average age was 63.5 years and baseline eGFR was 77.9 mL/min/1.73m(2). The average rate of eGFR decline was -2.0 +/- 4.7 mL/min/1.73m(2)/year. When modeled on top of established risk markers, the biomarker panel including matrix metallopeptidases, tyrosine kinase, podocin, CTGF, TNF-receptor-1, sclerostin, CCL2, YKL-40, and NT-proCNP improved the explained variability of eGFR decline (R-2 increase from 37.7% to 54.6%; p=0.018) and improved prediction of accelerated eGFR decline (C-index increase from 0.835 to 0.896; p=0.008).

Conclusions

A novel panel of biomarkers representing different pathways of renal disease progression including inflammation, fibrosis, angiogenesis, and endothelial function improved prediction of eGFR decline on top of established risk markers in type 2 diabetes. These results need to be confirmed in a large prospective cohort.

Original languageEnglish
Article number0120995
Number of pages16
JournalPLoS ONE [E]
Volume10
Issue number5
DOIs
Publication statusPublished - 14 May 2015

Keywords

  • CHRONIC KIDNEY-DISEASE
  • GLOMERULAR-FILTRATION-RATE
  • ENDOTHELIAL DYSFUNCTION
  • NEPHROPATHY
  • MELLITUS
  • PLASMA
  • MICROALBUMINURIA
  • ALBUMINURIA
  • PROGRESSION
  • INFLAMMATION

Fingerprint

Dive into the research topics of 'A Panel of Novel Biomarkers Representing Different Disease Pathways Improves Prediction of Renal Function Decline in Type 2 Diabetes'. Together they form a unique fingerprint.

Cite this